Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener Medizinische Wochenschrift
Erschienen in:

06.02.2019 | consensus paper

Radiofrequency ablation of thyroid nodules: “Good Clinical Practice Recommendations” for Austria

An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH)

verfasst von: Harald Dobnig, M.D., Wolfgang Zechmann, Michael Hermann, Michael Lehner, Dirk Heute, Siroos Mirzaei, Alois Gessl, Vinzenz Stepan, Günter Höfle, Philipp Riss, Andrea Simon

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 1-2/2020

Einloggen, um Zugang zu erhalten

Summary

The present “Good Clinical Practice Recommendations” relate to radiofrequency ablation (RFA) training, execution, and quality control, as well as to pre- and postinterventional standards of care. They are aimed at all physicians who intend to learn to perform, or who are already conducting RFA interventions as well as at thyroid specialists providing pre- and postoperative care to RFA patients in Austria. Adoption of these recommendations is strongly encouraged by the afore-listed professional associations.
All RFA interventionists who adhere to these standards shall be listed on a homepage linked to these professional associations entitled “RFA centers in compliance with the GCP recommendations of the ÖSDG/OGNMB/ÖGES/OEGCH-ACE.” This will ensure harmonization of RFA training and quality control in the performance of the treatment in Austria.
Vorheriger Artikel Briefsammlung Wittelshöfer
Nächster Artikel Aktuelle Diskussion zur risikoadaptierten Therapie des differenzierten Schilddrüsenkarzinoms: Ist weniger (Therapie) wirklich mehr?
Fußnoten
1
To improve its readability this text has been written without gender-specific referencing. Unless stated otherwise, all terms apply to both women and men.
 
2
Compiled by author (HD).
 
Literatur
1.
Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid. 2006;16:361–7.CrossRef
2.
Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18:1244–50.CrossRef
3.
Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010;194:1137–42.CrossRef
4.
Sung JY, Baek JH, Kim KS, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology. 2013;269:293–300.CrossRef
5.
6.
Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015;36:1321–5.CrossRef
7.
Deandrea M, Sung JY, Limone P, et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid. 2015;25:890–6.CrossRef
8.
Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015;21:887–96.CrossRef
9.
Cesareo R, Pasqualini V, Simeoni C, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab. 2015;100:460–6.CrossRef
10.
Dobnig H, Amrein K. Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single-center study. Thyroid. 2018;28:472–80.CrossRef
11.
12.
Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19:167–74.CrossRef
13.
Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015;100:1903–11.CrossRef
14.
15.
Kohlhase KD, Korkusuz Y, Groner D, et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperthermia. 2016;32:511–6.CrossRef
16.
Korkusuz Y, Mader A, Groner D, et al. Comparison of mono- and bipolar radiofrequency ablation in benign thyroid disease. World J Surg. 2017;41:2530–7.CrossRef
17.
Barile A, Quarchioni S, Bruno F, et al. Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 2018;7:132–46.CrossRef
18.
Gharib H, Hegedus L, Pacella CM, et al. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98:3949–57.CrossRef
19.
Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13:117–25.CrossRef
20.
Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19:632–55.CrossRef
21.
Garberoglio R, Aliberti C, Appetecchia M, et al. Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound. 2015;18:423–30.CrossRef
22.
Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules—2016 update. Endocr Pract. 2016;22:622–39.CrossRef
23.
Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26:1581–7.CrossRef
24.
P. Mikosch, H. J. Gallowitsch, E. Kresnik, J. Jester, F.G. Würtz, K. Kerschbaumer, O. Unterweger, H.P. Dinges, P. Lind, (2000) Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area. European Journal of Nuclear Medicine 27 (1):62-69CrossRef
25.
Wang JF, Wu T, Hu KP, et al. Complications following radiofrequency ablation of benign thyroid nodules: A systematic review. Chin Med J 2017;130:1361-70.CrossRef
Metadaten
Titel
Radiofrequency ablation of thyroid nodules: “Good Clinical Practice Recommendations” for Austria
An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH)
verfasst von
Harald Dobnig, M.D.
Wolfgang Zechmann
Michael Hermann
Michael Lehner
Dirk Heute
Siroos Mirzaei
Alois Gessl
Vinzenz Stepan
Günter Höfle
Philipp Riss
Andrea Simon
Publikationsdatum
06.02.2019
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 1-2/2020
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-019-0682-2

Weitere Artikel der Ausgabe 1-2/2020

Schilddrüse

  • editorial

Schilddrüse und Schwangerschaft: Schein und Sein

Apps in der Sekundärprävention nach Schlaganfall

  • Open Access
  • übersicht

Briefsammlung Wittelshöfer

  • wmw history

Aktuelle Diskussion zur risikoadaptierten Therapie des differenzierten Schilddrüsenkarzinoms: Ist weniger (Therapie) wirklich mehr?

  • themenschwerpunkt

Hashimoto Thyreoiditis – ein aktueller Überblick